Painkillers masking or reducing prostate cancer?

Professional Adviser
clock

Painkillers such as aspirin and ibuprofen could lower a protein often used to determine if a person ...

Painkillers such as aspirin and ibuprofen could lower a protein often used to determine if a person is at risk of developing prostate cancer. The study, conducted by the University of Rochester Medical Centre, found that levels of prostate specific antigen (PSA) in men over the age of 40 were 10% lower in those who regularly took the painkillers than in those who did not. Dr Eric Singer, a urology resident at the centre, said that it was still too soon to determine if the painkillers, called non-steroidal anti-inflammatory drugs (NSAIDs), would be effective at reducing the risk of devel...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on uncategorised

Robert Peston confirmed as PA360 keynote speaker

Robert Peston confirmed as PA360 keynote speaker

Join Peston and PA in London in April

Professional Adviser
clock 26 January 2026 • 1 min read
Brooks Macdonald becomes BAFTA wealth management partner

Brooks Macdonald becomes BAFTA wealth management partner

Partnership starts in 2026

Jen Frost
clock 08 December 2025 • 1 min read
As Reeves scrabbles for Budget funds, is she missing a Covid furlough trick?

As Reeves scrabbles for Budget funds, is she missing a Covid furlough trick?

Creativity key as chancellor faces tough tax and spending choices

Jen Frost
clock 21 November 2025 • 8 min read